tradingkey.logo
tradingkey.logo
검색

Amneal Pharmaceuticals Inc

AMRX
관심 목록에 추가
17.310USD
+0.020+0.12%
종가 06/30, 16:00ET시세는 15분 지연됩니다
5.52B시가총액
44.64P/E TTM

Amneal Pharmaceuticals Inc

17.310
+0.020+0.12%

자세한 내용은 Amneal Pharmaceuticals Inc 회사

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc 정보

종목 코드 AMRX
회사 이름Amneal Pharmaceuticals Inc
상장일Nov 18, 2009
CEOPatel (Chintu)
직원 수8100
유형Ordinary Share
회계 연도 종료Nov 18
주소400 Crossing Boulevard, 3rd Floor
도시BRIDGEWATER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호08807
전화19089473120
웹사이트https://amneal.com/
종목 코드 AMRX
상장일Nov 18, 2009
CEOPatel (Chintu)

Amneal Pharmaceuticals Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

자주 묻는 질문

Amneal Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?

Amneal Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Mr. Chintu Patel

Amneal Pharmaceuticals Inc(AMRX)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Amneal Pharmaceuticals Inc의 주식을 보유한 기관은 총 521곳이며, 이들이 보유한 주식의 총 가치는 약 161.64M로 전체 발행 주식의 50.67%를 차지합니다. 이는 2025Q4 대비 -25718515.00 증가한 수치입니다.

Amneal Pharmaceuticals Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Amneal Pharmaceuticals Inc의 Oral solid 부문이 가장 높은 매출을 기록했으며, 금액은 726.38M로 전체 매출의 24.06%를 차지했습니다.
KeyAI